ADILNasdaqPharmaceutical PreparationsFiscal year ends December 31
ADIAL PHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.62+0.13 (+3.72%)
Close on Oct 19, 2026
- Market cap
- $16.73M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$5.38 (−59.77%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $16.73M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$57.80M
- EPS, diluted
- -$11.93
- Book value per share
- -$8.30
- Diluted shares
- 5M
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Operating income
-$57.68M
Net income
-$57.80M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months